| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01fdb9b8031226b2d4b162baf45da5ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_529c77b71106c16baa814144df3ff227 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2018-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a07c1bbc7690f3007155f7dda4ecf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42cd757e8c06ca4053ef2cc90af30d62 |
| publicationDate |
2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RO-134194-A2 |
| titleOfInvention |
DRUG COMPOSITION FOR PREPARATION OF MANAGEMENT DIABETES |
| abstract |
The invention relates to a medicament composition for the prophylaxis of gestational diabetes. The composition according to the invention consists of 500 mg of mesoinositol, 75 mg of ascorbic acid, 82.5 mg of calcium ascorbate, as well as the usual excipients for the tablet form. |
| priorityDate |
2018-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |